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Abstract
Background: Cervical cancer is highly preventable and treatable if detected early through regular screening.
Women in the Canadian province of Newfoundland & Labrador have relatively low rates of cervical cancer screening,
with rates of around 40 % between 2007 and 2009. Persistent infection with oncogenic human papillomavirus (HPV) is
a necessary cause for the development of cervical cancer, and HPV testing, including self-sampling, has been suggested
as an alternative method of cervical cancer screening that may alleviate some barriers to screening. Our objective was
to determine whether offering self-collected HPV testing screening increased cervical cancer screening rates in rural
communities.
Methods: During the 2-year study, three community-based cohorts were assigned to receive either i) a cervical
cancer education campaign with the option of HPV testing; ii) an educational campaign alone; iii) or no intervention.
Self-collection kits were offered to eligible women at family medicine clinics and community centres, and participants
were surveyed to determine their acceptance of the HPV self-collection kit. Paired proportions testing for before-after
studies was used to determine differences in screening rates from baseline, and Chi Square analysis of three dimensional
2 × 2 × 2 tables compared the change between communities.
Results: Cervical cancer screening increased by 15.2 % (p < 0.001) to 67.4 % in the community where self-collection
was available, versus a 2.9 % increase (p = 0.07) in the community that received educational campaigns and 8.5 % in
the community with no intervention (p = 0.193). The difference in change in rates was statistically significant between
communities A and B (p < 0.001) but not between communities A and C (p = 0.193). The response rate was low, with only
9.5 % (168/1760) of eligible women opting to self-collect for HPV testing. Of the women who completed self-collection,
15.5 % (26) had not had a Pap smear in the last 3 years, and 88.7 % reported that they were somewhat or very satisfied
with self-collection.
Conclusions: Offering self-collected HPV testing increased the cervical cancer screening rate in a rural NL community.
Women who completed self-collection had generally positive feelings about the experience. Offering HPV self-collection
may increase screening compliance, particularly among women who do not present for routine Pap smears.
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Background
Cervical cancer is preventable and treatable if detected
early. Persistent infection with oncogenic human papillo-
mavirus (HPV) is a necessary cause of cancer [1, 2]. While
most HPV infections are transient and clear in 12 to
18 months [3, 4], women who have persistent infection
with oncogenic HPV are at increased risk of pre-cancerous
lesions and cervical cancer. Asymptomatic cervical HPV
infection can be detected in 5–40 % of women of repro-
ductive age with the prevalence declining with advancing
age [5]. The relative risk for the association between HPV
infection and cervical neoplasia is of high magnitude, typ-
ically in the 20–70 range [5]. This range is greater than
that for the association between smoking and lung cancer
and is comparable only to that of the association between
chronic hepatitis B infection and liver cancer [5].
In countries where Pap smear screening is widely avail-
able, studies have shown that more than half of all invasive
cervical cancers are diagnosed in women who are under-
or un-screened [6, 7]. These studies have also suggested
that up to 30 % of women diagnosed with invasive cervical
cancer were considered adequately screened by Pap smear
[6, 7]. Self-collected HPV testing has been suggested as an
effective cervical cancer screening tool that is acceptable
to women and may encourage better adherence to regular
screening, particularly among women who are under-
screened [8–10]. Studies have demonstrated that detecting
early cell changes earlier using HPV does prevent some
cancers [11–13] and women report satisfaction with self-
sampling and a willingness to screen in this manner [14].
Self-sampled HPV testing alleviates some of the discomfort
and embarrassment that some women feel with a Pap
smear, which may be a barrier to screening [15, 16]. The
use of HPV testing as a primary screening tool is still the
subject of debate in the literature. The Canadian Task
Force for Preventive Health Care felt there was insufficient
evidence to endorse HPV testing as a method of primary
cervical cancer screening in its 2013 recommendations
[17], but a self-sampled HPV test has been approved as a
primary screening tool in the US [18] and many studies
continue to evaluate the potential of this technology in
low-resource settings [19, 20].
It has long been known that individuals living in rural
communities have poorer prognosis for a variety of
health conditions [21], including an adjusted cancer sur-
vival rate that is 5–7 % lower than their urban-
dwelling peers [22]. Referral delays, lack of providers,
providers’ attitudes toward screening [23], and limited
access to screening [24] are cited as potential reasons
for this disparity. Self-sampled HPV testing has been
studied as a way to screen women for cervical cancer
in rural parts of developing countries [25, 26], but its
efficacy and effectiveness in rural and remote regions of
developed nations is less understood.
Taking this into consideration, we devised a community-
based study in rural areas of Newfoundland and Labrador
(NL), Canada, to determine whether offering self-
collected HPV testing might be an effective tool to
increase cervical cancer screening participation. Despite
comprehensive education programs and promotional
campaigns, only 43 % of women in NL participated in
Pap smear screening from 2007–2009 [27]. Our object-
ive was to determine if the introduction of a self-
collection strategy for HPV screening would increase
primary cervical cancer screening in a community-based
setting in rural NL.
Method
Study design
This study used a community-based cohort design target-
ing women aged 30–69 years, excluding pregnant women.
Three communities in NL with similar demographics
(Table 1) that were far enough apart to avoid contamin-
ation were identified (minimum 140 km or 86 mi by road,
see Fig. 1). The two intervention communities (Communi-
ties A and B) were rural communities of similar size and
demographic composition with the presence of academic
faculty members to oversee the research. The control com-
munity was selected because it was demographically simi-
lar to the two study communities. The eligible study
populations before and after the intervention, used to cal-
culate participation rates, were determined using census
data from the 2006 to 2011 Canadian census [28, 29].
Potential participants living in Community A were
given the option of being screened for HPV infection
through a vaginal self-collection method and were also
encouraged to undergo a Pap smear screening test done
by their primary health care provider; Communities B and
C had the continued availability of Pap smears for cervical
cancer screening (Table 2). Educational and promotional
activities in Communities A and B raised awareness
about the prevalence and preventability of cervical cancer,
the importance of regular screening. In Community A
this promotional campaign included information about
the availability of self-collected HPV testing offered as
part of a research project while in Community B the
focus was on the importance of Pap smears. Community
C received no intervention beyond the normal public
education initiatives conducted by the provincial cervical
screening program. Research nurses carried out all educa-
tional activities in Communities A and B.
The Newfoundland and Labrador Human Research
Ethics Board reviewed and approved the study. All partici-
pants provided informed consent prior to enrollment.
Self-collection kit
The HPV self-collection kit was assembled by the
Newfoundland & Labrador Public Health Laboratory
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and included a Dacron swab, collection tube, instruc-
tions with explanatory pictures, consent forms and a
participant questionnaire examining demographic infor-
mation, knowledge of Pap smear screening, frequency
of screening, and satisfaction with the self-collection
process. Kits were available at public locations such
as the hospital, pharmacies, hair salons and women’s
exercise centers. The research nurse was also available
to drop off kits at a woman’s home or work. Once
the kit was completed women could drop it off at the
local hospital or call the research nurse and she
would pick up the kit at a place and time of their
convenience. The kits were sent to the Public Health
Laboratory in St. John’s, NL for HPV DNA testing
within 2 weeks of sample collection. All participating
women signed written consent for involvement in the
study. Patients and their primary care providers were
contacted to provide the results of the HPV testing and
suggestions of the next steps (Fig. 2). Women who tested
negative for HPV were given a pamphlet explaining the
importance of continuing regular screening for cervical
cancer while women who were positive for HPV were
given an informational pamphlet about HPV and a
recommendation to follow-up with their primary care
provider for Pap smear screening.
Educational and promotional campaigns
The province of NL has a Cervical Screening Initiative
promotes cervical cancer screening through regular
educational and promotional activities. The Initiative
distributes informational pamphlets and posters, provides
educational sessions in the community, and promotes
cervical cancer awareness and screening through radio
and newspaper advertisements. The Initiative also has an
opt-in program where primary caregivers are notified
when their patients are due to be screened by Pap smear.
Regional personnel oversee the Initiative’s promotional
activities, and individual primary care providers may
have their own strategies to promote screening among
their patients.
The research nurse in Communities A and B gave
presentations on cervical cancer screening to various
community groups as part of an educational campaign.
Women in Community A were also given the option
to take a self-collection kit at the conclusion of the
presentation. In Community A the research nurse
held drop-in clinics where women could pick up or
drop off kits, get help filling out paperwork or ask
any questions they may have. In Community B, par-
ticipating women completed a questionnaire about
Pap smear screening at the time of a scheduled Pap
smear or after attending an educational session. In Com-
munities A and B the campaign to promote screening
through HPV self-collection or Pap smear, respectively, was
promoted through radio ads, newspaper ads and commu-
nity newsletters, and other local media and community
groups (Table 3). The degree of penetration of the promo-
tional and educational campaigns was assessed via tele-
phone survey of 15 % of non-commercial listed phone
numbers approximately a year after the study began.
Statistical analysis
Demographics were described for study participants in
each region, with age, marital status, and level of educa-
tion grouped categorically. The cervical cancer screen-
ing history of participants in Communities A and B was
assessed to categorize their screening status as regularly
screened (had Pap smear in past 3 years), under-
screened (last Pap smear between 3 and 5 years ago) or
unscreened (never had a Pap smear).
The cervical cancer screening rates were calculated for
each community for the 2 years prior to the study (2008
and 2009) and the two years the study was in place (2010
and 2011). Pap smear data was provided by the provincial
Cervical Screening Initiatives Program. For Community A
the cervical cancer screening rate included those screened
by Pap smear or by self-collection for HPV screening; indi-
viduals who were screened by self-collection and Pap
smear during the study period were identified and counted
only once. For Communities B and C the screening rates
were calculated using provincial Pap smear screening data.
Paired proportions testing for Before-After studies was
used to determine the statistical significance of the
change in screening rates for each community. We
then compared the change in screening rates between
Community A and each of Community B and
Table 1 Population and demographics for the study communities at beginning of study based on 2006 data
Community Community catchment
area population
N (%) of women aged 30–69
in community catchment area
Personal income per capita Employment rate Pap smear rates
A 6280 1928 (30.7 %) $16,900 75.2 % 41 %
B 6475 2833 (43.8 %) $18,400 70.4 % 38 %
C 5355 1524 (28.6 %) $16,600 63.3 % 45 %
These are three rural communities around the coast of the island of Newfoundland, Canada. There locations around the island are shown in Fig. 1. Fishing,
logging, water based transportation, and services industries are the main sources of employment. The people are almost exclusively Caucasian
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Fig. 1 Approximate location of the three study communities on the island of Newfoundland
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Community C using Chi Square analysis of 3-dimension
2 × 2 × 2 tables to determine if the intervention resulted in
significantly different changes in screening rates in the
intervention community compared to the control
communities.
Results
Study demographics and community participation
There were an estimated 1928 women aged 30–69 years
of age in Community A, 2833 in Community B, and
1524 in Community C at the beginning of the study. By
Table 2 Screening and educational interventions in the three communities included in the study
Community A Community B Community C
Screening HPV self-collection in addition to regular
Pap test screening
Regular Pap test screening Regular Pap test screening
Education Intense educational and promotional campaign
about HPV, self-collection and cervical cancer
screening in addition to regular provincial
education campains
Intense educational and promotional
campaign about cervical cancer screening




Fig. 2 Flow sheet algorithm for follow-up of HPV test results
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the end of the study the populations of eligible women
in Communities A, B and C were 1760, 2761, and 1536
respectively.
Eight hundred and thirty seven HPV self-collection kits
were taken from the distribution sites in Community A
during 2010 and 2011, and 168 (20.1 %) of these were
returned for processing. The overall response rate of
eligible women to self-collection in Community A
was 9.5 % (168/1760). In Community B, 374 (13.5 %)
women presenting for Pap smears agreed to be part
of the study and provided information on themselves
and their screening history.
The participants in Communities A and B were similar
demographically, although Community A had significantly
more women with less than a high school education and
fewer women with a college degree (Table 4). A majority
of participants in both communities were married and
had at least some post-secondary education.
The telephone survey assessing the penetration of the
educational and promotional campaigns indicated that
well over half of the eligible women in Community A
(167/276, 74.6 %) and just under a third of eligible women
in Community B (117/381, 30.7 %) were aware of the
cervical cancer research study in their area.
Cervical cancer screening history, participation rate,
HPV positivity and participant satisfaction
Twenty-six of the women (15.5 %) who completed
self-collection in Community A and 52 women (13.9 %)
who completed a questionnaire in Community B were
under- or un-screened by our definitions. In Community
A, 40 women (23.8 %) used self-collection as their only
form of cervical cancer screening during the study period.
Seven (4.17 %) study participants in Community A tested
positive for HPV. Of the women who tested positive
for HPV and followed up with the recommended Pap
smear, two were found to have a low-grade squamous
intraepithelial lesion, one of whom was under-screened.
Overall, participant satisfaction with the kits was high,
with 114 (67.9 %) participants stating they were very
satisfied with the self-collected HPV test, 35 (20.8 %)
were somewhat satisfied and 9 (5.4 %) were uncertain.
Only 1 (0.6 %) woman was somewhat dissatisfied and
no women were very dissatisfied with the kit. One
hundred and fifty three women (91.1 %) said they
would use the kit again to regularly screen for HPV.
Change in cervical cancer screening rates
There was a statistically significant increase in screening
rates in Community A (15.2 % increase; p < 0.001) and
Community C (8.5 % increase; p <0.01) during the 2010/
2011 period compared to the 2008/2009 period (Table 5).
The 2.9 % change in screening rates for Community B
was not statistically significant. The change in screening
rate for Community A was significantly greater than the
change in screening rate in Community B (p <0.001).
The change in screening rate in Community A was




In Community A the cervical cancer screening rate (Pap
smear or HPV testing as screen) increased by 15.2 %
during the 2 years of the study. This is statistically and,
we believe, clinically significant. In Community B the
rate increased by only 2.9 % during the study period.
This suggests that the availability of self-collection in
Community A did improve cervical cancer screening rates
beyond the effect of simply having an intense educational
and media campaign.
Despite a comparable screening rate of 45 % in 2006,
Community C had a screening rate of 72 % in the two
years prior to the study, and the screening rate increased
by 8.5 % (p < 0.001) during the study period. Our study
was conducted during a period of time when awareness
of the low cervical cancer screening rate was increasing.
The overall proportion of women considered adequately
screened in the province rose from 68.2 % during
2006–2008 to 74.4 % during 2009–2011, changing NL
from a province with one of the lowest participation
rates in the country to among the highest in just 3 years
[30, 31]. The provincial Cervical Screening Initiatives edu-
cational and promotional campaigns continued in all three
communities. Through personal communications with a
Table 3 Promotional activities carried out in Community A and
Community B
Category Community A Community B
Newspaper adsa 15 13
Online newspaper adsa 5 5
Newspaper articlesa 2 1
Public Service Adsa 48 55
Radio Adsa 7 7
Radio Interview 1 −
Community Newslettersa 4 1
Church Bulletins 20 −
Facebook Page 1 1
Facebook Advertising 1 1
Digital Community Signa − 4
Nurse Presentations 37 presentations 34 presentations
17 promotions
44 drop-in clinics
aFor these activities, the number represents the number of times the promotion
was carried out over a 1 week period. For example, in Community A, ads were
put in the local newspaper 15 times for a total of 15 weeks in circulation
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senior physician in the area, we also learned of a nurse
practitioner and a young family physician in Community
C who both began practicing in the community immedi-
ately prior to and during the study period, both of
whom were proactive with cervical cancer screening.
These confounding factors may be responsible for the
unexpected increase in screening rates in our control
community.
Response rate
Our uptake rate was relatively low compared to other
studies of HPV self-collection programs. Of the 837 kits
that were picked up, only 168 (20.1 %) were returned,
and only 9.5 % of the eligible population of women
participated in HPV self-collection. Researchers in Mexico
completed a trial of women from low socioeconomic
status and obtained a response rate of 74.6 % [9]. Another
Table 4 Demographics of Participants in Community A and Community B
Variable Category Community A (n = 168) n(%) Community B (n = 374) n(%)
Age Group 30–34 14 (8.3 %) 34 (9.1 %)
35–39 9 (5.4 %)* 54 (14.4 %)*
40–44 22 (13.1 %) 46 (12.3 %)
45–49 29 (17.3 %) 58 (15.5 %)
50–54 31 (18.5 %) 59 (15.8 %)
55–59 32 (19 %) 55 (14.7 %)
60–64 21 (12.5 %) 34 (9.1 %)
65–69 6 (3.6 %) 21 (5.6 %)
unknown 4 (2.4 %) 13 (3.5 %)
Marital Status Married or Common Law 148 (88.1 %) 310 (82.9 %)
Divorced 3 (1.78 %) 10 (2.7 %)
Separated 2 (1.19 %) 13 (3.5 %)
Widowed 4 (2.38 %) 14 (3.7 %)
Single or Never Married 9 (5.36 %) 19 (5.1 %)
Unknown 2 (1.19 %) 8 (2.1 %)
Education < High school 49 (29.17 %)* 59 (15.8 %)*
High school diploma 44 (26.19 %) 100 (26.7 %)
Some College 6 (3.57 %)* 32 (8.6 %)*
College Diploma or Certificate 45 (26.79 %) 114 (30.5 %)
Some University 6 (3.57 %) 16 (4.3 %)
University Degree, Diploma, or Certificate 17 (10.11 %) 45 (12.0 %)
Unknown 1 (0.6 %) 8 (2.1 %)
Pap smear screening history Regularly screened 142 (84.5 %) 322 (85.9 %)
Under screened 25 (14.9 %) 39 (10.4 %)
Unscreened 1 (0.6 %) 13 (3.5 %)*
Unknown 2 (1.2 %) 1 (0.3 %)
* denotes significant differences in proportions at a significance level of 0.05
Table 5 Rate of cervical cancer screening in the three communities prior to and during the study
Community Cervical cancer screening
rate 2008/2009 n/Na (%)
Cervical cancer screening
rate 2010/2011 n/Na (%)
Change in rate from
2008/2009 to 2010/2011
P Value for before-after
change in each community
P Value for difference
in change in rates
A 1020/1928 (52.9 %) b1187/1760 (67.4 %) +15.2 % <0.001 Ref.
B 1484/2833 (52.4 %) 1529/2761 (55.3 %) +2.9 % 0.07 <0.001
C 1098/1524 (72.0 %) 1236/1536 (80.5 %) +8.5 % <0.01 0.193
aDenominator (eligible populations of women age 30–69 years) for the 2008/2009 period is based on 2006 census data and for the 2010/2011 period it is based
on 2011 census data
bFor years 2010 and 2011 for Community A the screening rate was determined by adding the number of women who had a Pap smear to the women who did
self-collection but did not have a Pap smear to avoid counting in duplicate those women who self-collected and had a Pap smear
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study in rural Mississippi offered under-screened women
the opportunity to self-collect for HPV in their homes or
to have a pap smear and 64.7 % chose to self-collect for
HPV [32]. In both these studies, however, nurses went
directly to participants’ homes and helped them with
their sample and paperwork. This type of specialized
care would no doubt increase participation rates;
however in the general population such intervention
is not feasible for each and every woman.
Our objective was to evaluate whether the introduction
of self-collected HPV kits alongside traditional Pap smears
would increase overall screening in the community. This
makes our study more comparable to other screening
programs in the country where people are responsible for
initiating or completing their own testing. For example,
colorectal cancer screening initiatives have participation
rates of 23 % in Manitoba (2009/10) [33] and 27 % in
Ontario (2009/10) [34]. In Newfoundland and Labrador
the participation in breast cancer screening was 25.5 % in
2003–04 after 8 years of the program being in place [35].
These numbers are more comparable with our results.
One also wonders why 669 of the 837 kits that were
picked up were not returned. Self-collected HPV testing is
thought to overcome many of the barriers to participation
in Pap smear screening, including pain and discomfort
with pelvic exams, difficulty scheduling appointments,
transportation issues, and lack of access to primary care
providers, and many studies in the literature report much
higher response rates than we observed. In the question-
naires, many of our participants stated that the reason
they were under-screened was that they simply, “had not
gotten around to [having a Pap smear]” (31.3 %). Perhaps
the self-collection kit alleviates the barriers of time and
scheduling for some women, but clearly there are still
some impediments to wider use of the kits. Another
potential barrier was the amount of paperwork involved in
the study, which may have deterred some women with
lower educational levels to take but not return kits, when
they realized the amount of paperwork involved. The kit
contained instructions (3 pages), consent forms (6 pages)
and questionnaires (3 pages), for a total of 12 pages of
documents, which may have been overwhelming or too
time-consuming for participants.
The literature suggests that the method by which
women are provided with the HPV self-collection kits
may affect participation. An Italian study comparing
different self-sampling distribution methods found that
when kits were mailed directly to women, rather than
providing women the option to request a kit, the response
rate more than doubled from 8.7 % to 19.6 % [36]. It seems
that direct mailing, rather than ‘on demand’ screening
may increase participation. As the bulk of the cost of HPV
testing is incurred at the laboratory phase, distributing
the relatively inexpensive kits widely may, indeed, be cost
efficient. The kits used for our study cost $3 CAD each,
with an additional cost of $35 CAD plus technician time
for the HPV DNA assay at the time of our study, although
costs will vary by jurisdiction and are likely to decrease
over time. Distributing self-collected HPV kits directly to
women identified as under-screened through cervical
screening registries may be an efficient method to utilize
this technology, and the results from the study mentioned
previously indicate a willingness of these women to
participate in this way.
Of the women who completed self-collection, 88.8 %
found the process somewhat or very satisfactory. Fur-
thermore, 15.5 % (26) of the women who performed the
self-collection were under-screened or unscreened.
These women did not attend regular screening in the
past, and the self-collection kit provided a method that
they were more willing to use.
A discussion of cervical cancer screening would be in-
complete without the acknowledgement of the importance
of organized cervical screening programs. A systematic re-
view of methods to improve cervical cancer screening has
found standard recall letters to be effective at increasing
compliance with cervical cancer screening via Pap smear
[33]. Self-collection has been shown in our study and
others to be an effective method of increasing screening
rates, but we suggest that it would be most effective if
used as part of an organized screening program.
Implications for rural communities
Self-collection seems to alleviate some barriers to
screening in rural communities, but our study indicates
that the rate of uptake may hinder its utility. Self-
sampling is fast, women are overwhelmingly able to
collect adequate samples, and it can be implemented in
communities that have no or very few regular primary
care providers. However, our study makes clear the fact
that simply providing kits may not sufficiently encourage
women to self-collect, and further study of more tar-
geted or direct distribution methods is warranted prior
to wider use of this self-collected HPV testing.
Conclusion
Availability of a self-collection option increased the
cervical screening rate by 15.2 %. Twenty-six (15.5 %)
women who used self-collection in Community A had
been unscreened or under-screened prior to the study.
Twenty percent of the self-collection kits that were
taken from distribution sites were returned with sam-
ples. Participants found the self-collection test accept-
able. We feel self-collection should be considered as an
option for cervical cancer screening as part of an orga-
nized cervical screening program.
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